Biofrontera
BFRI
8 hedge funds and large institutions have $142K invested in Biofrontera in 2023 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 8 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
1.04% more ownership
Funds ownership: 0.15% → 1.18% (+1%)
38% less funds holding
Funds holding: 13 → 8 (-5)
63% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 8
66% less capital invested
Capital invested by funds: $413K → $142K (-$270K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CSPIA
Cary Street Partners Investment Advisory
Richmond,
Virginia
|
+$244 |
| 2 |
BlackRock
New York
|
+$10 |
| 3 |
JP Morgan Chase
New York
|
+$10 |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$10 |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$10 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BA
Bard Associates
Chicago,
Illinois
|
-$99.4K |
| 2 |
SSA
Schonfeld Strategic Advisors
New York
|
-$46K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
-$42.3K |
| 4 |
Renaissance Technologies
New York
|
-$26K |
| 5 |
State Street
Boston,
Massachusetts
|
-$11.9K |
BFRI Hedge Fund Activity: Q3 2023 in Review
8 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in Biofrontera (BFRI) for Q3 2023, worth a combined $142K — down 66% from $413K a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of BFRI and 3 opened new positions — a net loss of 5 holders — while 1 trimmed existing stakes and 3 added.
The largest buyer was Cary Street Partners Investment Advisory, opening a new position worth an estimated $244. The largest seller was Bard Associates, exiting entirely with an estimated $99.4K sold.
- 8 institutional investors held Biofrontera (BFRI) as of Q3 2023, down from 13 in Q2 2023.
- Funds reported $142K of Biofrontera stock for Q3 2023, down 66% quarter-over-quarter.
- 3 funds opened new Biofrontera positions in Q3 2023 and 8 closed out, a net change of -5 holders.
- The largest Biofrontera buyer in Q3 2023 was Cary Street Partners Investment Advisory, an estimated $244 added.
- The largest Biofrontera seller in Q3 2023 was Bard Associates, an estimated $99.4K sold.
Based on aggregated 13F filings for Q3 2023.